Table 2 Characteristics of stakeholders
Stakeholders | Netherlands | England |
|---|---|---|
In vitro diagnostics industry representatives | 1 (F) | 1 (M) |
Health insurance company representative | 1 (M) | – |
Clinical commissioning group member | – | 1 (M) |
Clinical guidelines development group member | 1 (M) | 1 (M) |
Member of NHS quality improvement programme (NHS Improvement) | – | 1 (F) |
CRP POCT tests implementors in primary care | 1 (M, head of hospital laboratory) | 1 (F, Nurse Practitioner) |
General practitioners | ||
 Consultants | 4 (2F) | 5 (1F) |
 Trainees | 2 (1F) | 1 (F) |
Total | 10 | 11 |